MedTrace Logo

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

NCT07474051 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2026-03-16

No results posted yet for this study

Summary

The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of patients who participated in an AvenCell-sponsored clinical trial and received treatment with AvenCell's UniCAR or RevCAR platforms.

Conditions

Interventions

BIOLOGICAL

UniCAR02-T (IMP) With Targeting Module TM123

No investigational product will be administered

BIOLOGICAL

UniCAR02-T-pPSMA

No investigational product will be administered

BIOLOGICAL

Allo-RevCAR01- T with Targeting Module R-TM123

No investigational product will be administered

BIOLOGICAL

Allo-QuadCAR01-T

No investigational product will be administered

Sponsors & Collaborators

  • AvenCell Europe GmbH

    collaborator INDUSTRY

  • AvenCell Therapeutics, Inc.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-29
Primary Completion
2040-11-30
Completion
2041-01-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07474051 on ClinicalTrials.gov